Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962689 | Vaccine | 2016 | 6 Pages |
Abstract
In our review of VAERS reports, IIV4 had a similar safety profile to IIV3. Most of the reported AEs were non-serious. Our findings are consistent with data from pre-licensure studies of IIV4.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Penina Haber, Pedro L. Moro, Paige Lewis, Emily Jane Woo, Christopher Jankosky, Maria Cano,